The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling

The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus...

Full description

Saved in:
Bibliographic Details
Published inJournal of virology Vol. 91; no. 3
Main Author Best, Sonja M.
Format Journal Article
LanguageEnglish
Published United States American Society for Microbiology 01.02.2017
Subjects
Online AccessGet full text

Cover

Loading…
Abstract The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures.
AbstractList The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes, facilitates large emergence events such as witnessed with Zika virus (ZIKV) or West Nile virus in the Americas. Every vector-borne flavivirus examined thus far that causes disease in humans, from dengue virus to ZIKV, antagonizes the host type I interferon (IFN-I) response by preventing JAK-STAT signaling, suggesting that suppression of this pathway is an important determinant of infection. The most direct and potent viral inhibitor of this pathway is the nonstructural protein NS5. However, the mechanisms utilized by NS5 from different flaviviruses are often quite different, sometimes despite close evolutionary relationships between viruses. The varied mechanisms of NS5 as an IFN-I antagonist are also surprising given that the evolution of NS5 is restrained by the requirement to maintain function of two enzymatic activities critical for virus replication, the methyltransferase and RNA-dependent RNA polymerase. This review discusses the different strategies used by flavivirus NS5 to evade the antiviral effects of IFN-I and how this information can be used to better model disease and develop antiviral countermeasures.
Author Best, Sonja M.
Author_xml – sequence: 1
  givenname: Sonja M.
  surname: Best
  fullname: Best, Sonja M.
  organization: Laboratory of Virology, Rocky Mountain Laboratories, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Hamilton, Montana, USA
BackLink https://www.ncbi.nlm.nih.gov/pubmed/27881649$$D View this record in MEDLINE/PubMed
BookMark eNqNkc1rGzEQxUVJaJyPW89Fxx66iUbSaqVLIYS6dcgXxAntSWhlraOylhxJNvi_77pJSht6KAwMzPzm8Zi3j3ZCDA6hd0COAag8Ob-fHBNQDalAvEEjIEpWdQ18B40IobSqmfy2h_Zz_kEIcC74W7RHGylBcDVC36cPDl-asMFjY13GscNlmIx7s_Zrn1YZX93W-CbF4nzAQ52GYuYx-LzYstPN0uEJnoTiUudSDPjWz4PpfZgfot3O9NkdPfcDdDf-PD37Wl1cf5mcnV5UlktWKibbhrW8FnbGOuiY6agVZuiKtpbPpOka4BaIq5kAKcmMCtUKa4hqHDTcsAP06Ul3uWoXbmZdKMn0epn8wqSNjsbrvzfBP-h5XOuacs64GgQ-PAuk-LhyueiFz9b1vQkurrIGKSRjNVXyP1DOlFCM0AF9_6et335eXj8A9AmwKeacXKetL6b4uHXpew1Eb_PVQ776V74axHD08dXRi-4_8Z-QjKW8
CitedBy_id crossref_primary_10_3389_fimmu_2021_671471
crossref_primary_10_1186_s12974_021_02180_5
crossref_primary_10_3390_microorganisms10050854
crossref_primary_10_1016_j_bbrc_2019_06_064
crossref_primary_10_1007_s00705_023_05883_7
crossref_primary_10_3390_vaccines12080865
crossref_primary_10_1128_JVI_01086_20
crossref_primary_10_1016_j_actatropica_2021_106199
crossref_primary_10_1016_j_bbamcr_2023_119536
crossref_primary_10_1016_j_antiviral_2018_09_006
crossref_primary_10_1038_s42003_024_05768_8
crossref_primary_10_1155_2020_1372494
crossref_primary_10_1128_JVI_00640_19
crossref_primary_10_3390_pathogens8040169
crossref_primary_10_1016_j_virusres_2024_199431
crossref_primary_10_1016_j_mam_2021_100994
crossref_primary_10_1073_pnas_2220005120
crossref_primary_10_3390_pathogens9070589
crossref_primary_10_1016_j_immuni_2020_11_019
crossref_primary_10_1128_JVI_00313_19
crossref_primary_10_1007_s00335_018_9775_2
crossref_primary_10_1016_j_celrep_2021_109888
crossref_primary_10_1021_acs_jproteome_9b00318
crossref_primary_10_3389_fcimb_2018_00149
crossref_primary_10_1073_pnas_2403235121
crossref_primary_10_3390_ijms21165906
crossref_primary_10_3389_fimmu_2022_829433
crossref_primary_10_1016_j_ajog_2018_08_035
crossref_primary_10_3390_v14051026
crossref_primary_10_1073_pnas_2101713118
crossref_primary_10_1007_s00018_018_2968_8
crossref_primary_10_1002_rmv_2166
crossref_primary_10_1155_2017_1734151
crossref_primary_10_3390_v10070340
crossref_primary_10_1021_acs_jnatprod_1c01161
crossref_primary_10_1016_j_jve_2024_100368
crossref_primary_10_3390_v17010001
crossref_primary_10_1080_07391102_2020_1742205
crossref_primary_10_3390_cells8121519
crossref_primary_10_1186_s12862_017_1107_8
crossref_primary_10_1016_j_jsb_2025_108196
crossref_primary_10_3390_v13102099
crossref_primary_10_1128_mBio_02904_18
crossref_primary_10_3390_cells13070598
crossref_primary_10_21769_BioProtoc_2643
crossref_primary_10_1038_s41564_019_0421_x
crossref_primary_10_1016_j_cyto_2020_155342
crossref_primary_10_1016_j_jviromet_2024_115053
crossref_primary_10_3390_v10070350
crossref_primary_10_1099_jgv_0_000992
crossref_primary_10_1016_j_bbrc_2017_10_016
crossref_primary_10_1002_eji_201847483
crossref_primary_10_1089_jir_2019_0097
crossref_primary_10_15252_embr_202357424
crossref_primary_10_3390_immuno4040033
crossref_primary_10_3390_v10120712
crossref_primary_10_1042_BCJ20220037
crossref_primary_10_1128_JVI_00058_20
crossref_primary_10_1093_nar_gkaa242
crossref_primary_10_3389_fviro_2022_935933
crossref_primary_10_1016_j_ebiom_2018_12_010
crossref_primary_10_3390_v14081666
crossref_primary_10_3389_fimmu_2023_1172000
crossref_primary_10_3390_v12101059
crossref_primary_10_3389_fimmu_2022_1031868
crossref_primary_10_3389_fcimb_2022_946957
crossref_primary_10_3389_fmicb_2023_1257024
crossref_primary_10_1016_j_jprot_2022_104619
crossref_primary_10_1038_s41564_024_01726_6
crossref_primary_10_1128_JVI_00163_17
crossref_primary_10_3389_fmicb_2022_757084
crossref_primary_10_3390_cells9040899
crossref_primary_10_3390_cells9061476
crossref_primary_10_1016_j_virol_2025_110456
crossref_primary_10_1242_dmm_040816
crossref_primary_10_3390_ijms25179424
crossref_primary_10_3390_vaccines9030294
crossref_primary_10_2217_fvl_2019_0037
crossref_primary_10_1096_fj_201900518R
crossref_primary_10_1128_JVI_00383_21
crossref_primary_10_7554_eLife_31919
crossref_primary_10_1111_cmi_12737
crossref_primary_10_3389_fimmu_2018_00722
crossref_primary_10_4049_jimmunol_1701773
crossref_primary_10_2174_0929867326666190111115132
crossref_primary_10_1007_s00018_018_2751_x
crossref_primary_10_1016_j_tracli_2017_05_005
crossref_primary_10_3390_v15051094
crossref_primary_10_1089_vim_2019_0082
crossref_primary_10_3390_ijms23010489
crossref_primary_10_3390_v9040091
crossref_primary_10_1016_j_ejmech_2021_113698
crossref_primary_10_3390_v16020202
crossref_primary_10_1128_JVI_01301_21
crossref_primary_10_1080_22221751_2022_2049983
crossref_primary_10_1080_07391102_2022_2141882
crossref_primary_10_1128_jvi_01982_22
crossref_primary_10_3390_v12070765
crossref_primary_10_3390_v14081808
crossref_primary_10_1007_s13365_017_0595_z
crossref_primary_10_3389_fcimb_2021_574067
crossref_primary_10_1080_21645515_2019_1609823
crossref_primary_10_1007_s12010_021_03526_8
crossref_primary_10_1016_j_jsps_2020_10_005
crossref_primary_10_1016_j_cyto_2019_02_009
crossref_primary_10_3390_microorganisms8091406
crossref_primary_10_1016_j_ymthe_2020_11_011
crossref_primary_10_1021_acsinfecdis_8b00373
crossref_primary_10_1016_j_virs_2022_12_005
crossref_primary_10_1128_JVI_00178_20
crossref_primary_10_1099_jgv_0_001400
crossref_primary_10_3390_ph18030283
crossref_primary_10_1038_s41598_020_64199_7
crossref_primary_10_3390_ijms21113812
crossref_primary_10_1016_j_celrep_2019_05_040
crossref_primary_10_1126_scisignal_aaw8549
crossref_primary_10_3390_microorganisms12091840
crossref_primary_10_1128_JVI_01778_18
crossref_primary_10_1007_s12250_018_0067_5
crossref_primary_10_3390_v9060143
Cites_doi 10.1074/jbc.M200018200
10.1016/j.chom.2016.05.009
10.1371/journal.ppat.1003265
10.1128/IAI.71.6.3000-3009.2003
10.1371/journal.pntd.0004658
10.1016/j.tcb.2014.05.001
10.1128/JVI.02188-08
10.1016/j.chom.2011.08.004
10.1128/JVI.03083-12
10.1128/JVI.00421-14
10.1038/nri2623
10.1126/science.aab3369
10.1089/vim.2010.0126
10.1146/annurev-virology-100114-055007
10.3389/fcimb.2014.00116
10.1038/nrm909
10.1128/JVI.79.9.5414-5420.2005
10.1016/j.jmb.2013.11.023
10.1038/nrmicro.2016.125
10.1038/nrmicro2950
10.1016/j.chom.2007.09.003
10.1016/j.chom.2016.03.010
10.1128/JVI.74.11.4957-4966.2000
10.1016/j.it.2015.02.002
10.1038/sj.onc.1203482
10.1016/j.chom.2014.07.015
10.1016/j.vaccine.2009.03.007
10.1016/j.immuni.2012.11.013
10.1128/JVI.80.6.2913-2923.2006
10.1128/JVI.00176-10
10.1016/j.jmb.2016.07.017
10.1146/annurev-immunol-032713-120231
10.1128/JVI.73.11.9247-9255.1999
10.1128/JVI.02097-12
10.1016/S0065-3527(03)61008-0
10.1128/mBio.01316-15
10.1128/JVI.79.20.12828-12839.2005
10.1016/j.chom.2010.10.007
10.1093/emboj/18.4.959
10.1128/JVI.00271-09
10.1371/journal.ppat.1004682
10.1016/j.virol.2015.01.019
10.4161/jkst.27715
10.1371/journal.ppat.1005143
10.1038/nri3133
10.1007/978-3-642-37765-5_2
10.1128/JVI.00791-07
10.1038/nri3210
10.1371/journal.pntd.0004682
10.1007/s00726-008-0055-4
10.1016/j.cell.2016.08.004
10.1128/JVI.02830-06
10.1128/JVI.02505-14
10.1002/pmic.201300001
10.1128/JVI.02050-10
10.1038/nri3581
10.3389/fmicb.2013.00176
10.1016/j.chom.2008.10.007
10.15252/embr.201642627
10.1016/j.ymeth.2011.08.003
10.1016/j.chom.2013.07.005
10.1038/nri3865
10.1111/j.1462-5822.2007.01076.x
10.1016/j.chom.2015.06.007
10.1126/science.aaf8325
10.1128/JVI.00207-12
10.1016/j.mib.2010.05.009
10.1128/JVI.00252-16
10.1371/journal.ppat.1005451
10.1074/jbc.M309749200
10.1128/JVI.00768-06
10.1371/journal.ppat.1000721
10.4049/jimmunol.174.12.8163
10.1128/JVI.78.17.9285-9294.2004
10.1038/nrmicro2595
10.1089/jir.2012.0117
10.1038/nature09907
10.3390/v4030397
10.1371/journal.pone.0090704
10.1038/nrmicro2675
10.1128/JVI.02283-06
10.1128/JVI.01239-15
10.1016/j.it.2015.01.004
10.1016/j.cytogfr.2014.08.004
10.1099/vir.0.014506-0
10.1128/JVI.02714-05
10.1371/journal.ppat.1002934
10.1086/605847
10.1016/j.chom.2016.06.001
10.1038/nature09489
10.4161/viru.2.3.16162
10.1038/nature12060
10.1128/JVI.01161-09
10.1128/JVI.80.9.4623-4632.2006
10.1073/pnas.1514978112
10.1128/JVI.01305-07
10.4269/ajtmh.16-0111
10.1128/JVI.01488-13
10.1128/JVI.79.3.1343-1350.2005
10.1038/nri3806
10.1089/jir.2009.0069
10.1128/JVI.79.3.1934-1942.2005
10.1073/pnas.2335168100
10.1016/j.vaccine.2012.11.015
10.1016/j.stem.2016.08.005
10.1016/j.cell.2016.05.008
10.1371/journal.ppat.1003549
ContentType Journal Article
Copyright Copyright © 2017 American Society for Microbiology.
Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology
Copyright_xml – notice: Copyright © 2017 American Society for Microbiology.
– notice: Copyright © 2017 American Society for Microbiology. 2017 American Society for Microbiology
DBID AAYXX
CITATION
CGR
CUY
CVF
ECM
EIF
NPM
7X8
7T5
7U9
H94
5PM
DOI 10.1128/JVI.01970-16
DatabaseName CrossRef
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Immunology Abstracts
Virology and AIDS Abstracts
AIDS and Cancer Research Abstracts
PubMed Central (Full Participant titles)
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
AIDS and Cancer Research Abstracts
Immunology Abstracts
Virology and AIDS Abstracts
DatabaseTitleList MEDLINE - Academic
CrossRef
AIDS and Cancer Research Abstracts

MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Biology
DocumentTitleAlternate Minireview
EISSN 1098-5514
ExternalDocumentID PMC5244349
27881649
10_1128_JVI_01970_16
Genre Journal Article
Review
GrantInformation_xml – fundername: Division of Intramural Research, National Institute of Allergy and Infectious Diseases (DIR, NIAID)
  grantid: 1ZIAAI001125-02
GroupedDBID ---
-~X
.55
.GJ
0R~
18M
29L
2WC
39C
3O-
4.4
41~
53G
5GY
5RE
5VS
6TJ
85S
AAFWJ
AAGFI
AAYJJ
AAYXX
ABPPZ
ACGFO
ACNCT
ADBBV
ADXHL
AENEX
AFFNX
AGVNZ
AI.
ALMA_UNASSIGNED_HOLDINGS
AOIJS
BAWUL
BTFSW
C1A
CITATION
CS3
D0S
DIK
E3Z
EBS
EJD
F5P
FRP
GX1
H13
HYE
HZ~
IH2
KQ8
MVM
N9A
O9-
OHT
OK1
P2P
RHI
RNS
RPM
RSF
TR2
UPT
VH1
W2D
W8F
WH7
WOQ
X7M
Y6R
YQT
ZGI
ZXP
~02
~KM
CGR
CUY
CVF
ECM
EIF
NPM
RHF
UCJ
7X8
7T5
7U9
H94
5PM
ID FETCH-LOGICAL-c483t-38b73b456cd3f1f3af2c6af3a92bc4d8af714c10e5361880d269b6ca097e174a3
ISSN 0022-538X
IngestDate Thu Aug 21 18:41:48 EDT 2025
Fri Jul 11 08:13:01 EDT 2025
Fri Jul 11 02:44:46 EDT 2025
Thu Jan 02 23:00:25 EST 2025
Tue Jul 01 01:02:47 EDT 2025
Thu Apr 24 22:59:17 EDT 2025
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 3
Keywords NS5
interferons
yellow fever virus
antagonism
JAK-STAT
West Nile virus
dengue virus
Zika virus
flavivirus
tick-borne encephalitis virus
Language English
License Copyright © 2017 American Society for Microbiology.
All Rights Reserved.
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c483t-38b73b456cd3f1f3af2c6af3a92bc4d8af714c10e5361880d269b6ca097e174a3
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-3
content type line 23
ObjectType-Review-1
ObjectType-Article-1
ObjectType-Feature-2
Citation Best SM. 2017. The many faces of the flavivirus NS5 protein in antagonism of type I interferon signaling. J Virol 91:e01970-16. https://doi.org/10.1128/JVI.01970-16.
OpenAccessLink https://jvi.asm.org/content/jvi/91/3/e01970-16.full.pdf
PMID 27881649
PQID 1843969302
PQPubID 23479
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_5244349
proquest_miscellaneous_1868335298
proquest_miscellaneous_1843969302
pubmed_primary_27881649
crossref_citationtrail_10_1128_JVI_01970_16
crossref_primary_10_1128_JVI_01970_16
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate 2017-02-01
PublicationDateYYYYMMDD 2017-02-01
PublicationDate_xml – month: 02
  year: 2017
  text: 2017-02-01
  day: 01
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
– name: 1752 N St., N.W., Washington, DC
PublicationTitle Journal of virology
PublicationTitleAlternate J Virol
PublicationYear 2017
Publisher American Society for Microbiology
Publisher_xml – name: American Society for Microbiology
References e_1_3_2_28_2
e_1_3_2_20_2
e_1_3_2_43_2
e_1_3_2_62_2
e_1_3_2_85_2
e_1_3_2_24_2
e_1_3_2_47_2
e_1_3_2_66_2
e_1_3_2_89_2
e_1_3_2_100_2
e_1_3_2_104_2
e_1_3_2_81_2
e_1_3_2_108_2
e_1_3_2_16_2
e_1_3_2_7_2
e_1_3_2_39_2
e_1_3_2_54_2
e_1_3_2_31_2
e_1_3_2_73_2
e_1_3_2_12_2
e_1_3_2_58_2
e_1_3_2_96_2
e_1_3_2_3_2
e_1_3_2_77_2
e_1_3_2_92_2
e_1_3_2_50_2
e_1_3_2_48_2
e_1_3_2_29_2
e_1_3_2_40_2
e_1_3_2_86_2
e_1_3_2_21_2
e_1_3_2_63_2
e_1_3_2_44_2
e_1_3_2_25_2
e_1_3_2_67_2
e_1_3_2_82_2
e_1_3_2_103_2
e_1_3_2_107_2
e_1_3_2_17_2
e_1_3_2_59_2
e_1_3_2_6_2
e_1_3_2_32_2
e_1_3_2_51_2
e_1_3_2_74_2
e_1_3_2_13_2
e_1_3_2_36_2
e_1_3_2_55_2
e_1_3_2_78_2
e_1_3_2_97_2
e_1_3_2_2_2
e_1_3_2_93_2
e_1_3_2_70_2
e_1_3_2_111_2
e_1_3_2_26_2
e_1_3_2_49_2
e_1_3_2_41_2
e_1_3_2_64_2
e_1_3_2_87_2
e_1_3_2_45_2
e_1_3_2_68_2
e_1_3_2_60_2
e_1_3_2_83_2
e_1_3_2_102_2
e_1_3_2_106_2
e_1_3_2_9_2
e_1_3_2_37_2
e_1_3_2_18_2
Lindenbach BD (e_1_3_2_23_2) 2007
e_1_3_2_75_2
e_1_3_2_10_2
e_1_3_2_52_2
e_1_3_2_5_2
e_1_3_2_33_2
e_1_3_2_79_2
e_1_3_2_14_2
e_1_3_2_56_2
e_1_3_2_98_2
e_1_3_2_94_2
e_1_3_2_71_2
e_1_3_2_110_2
e_1_3_2_90_2
Mashimo T (e_1_3_2_35_2) 2008; 321
e_1_3_2_27_2
e_1_3_2_65_2
e_1_3_2_42_2
e_1_3_2_84_2
e_1_3_2_69_2
e_1_3_2_46_2
e_1_3_2_88_2
e_1_3_2_61_2
e_1_3_2_80_2
e_1_3_2_101_2
e_1_3_2_109_2
e_1_3_2_105_2
e_1_3_2_15_2
e_1_3_2_38_2
e_1_3_2_8_2
e_1_3_2_19_2
e_1_3_2_30_2
e_1_3_2_53_2
e_1_3_2_76_2
e_1_3_2_99_2
e_1_3_2_11_2
e_1_3_2_34_2
e_1_3_2_57_2
e_1_3_2_95_2
e_1_3_2_4_2
e_1_3_2_91_2
e_1_3_2_72_2
Gubler DJ (e_1_3_2_22_2) 2007
References_xml – ident: e_1_3_2_100_2
  doi: 10.1074/jbc.M200018200
– ident: e_1_3_2_64_2
  doi: 10.1016/j.chom.2016.05.009
– ident: e_1_3_2_58_2
  doi: 10.1371/journal.ppat.1003265
– ident: e_1_3_2_95_2
  doi: 10.1128/IAI.71.6.3000-3009.2003
– ident: e_1_3_2_5_2
  doi: 10.1371/journal.pntd.0004658
– ident: e_1_3_2_57_2
  doi: 10.1016/j.tcb.2014.05.001
– ident: e_1_3_2_54_2
  doi: 10.1128/JVI.02188-08
– ident: e_1_3_2_36_2
  doi: 10.1016/j.chom.2011.08.004
– ident: e_1_3_2_60_2
  doi: 10.1128/JVI.03083-12
– ident: e_1_3_2_104_2
  doi: 10.1128/JVI.00421-14
– ident: e_1_3_2_19_2
  doi: 10.1038/nri2623
– ident: e_1_3_2_42_2
  doi: 10.1126/science.aab3369
– ident: e_1_3_2_83_2
  doi: 10.1089/vim.2010.0126
– ident: e_1_3_2_24_2
  doi: 10.1146/annurev-virology-100114-055007
– ident: e_1_3_2_93_2
  doi: 10.3389/fcimb.2014.00116
– ident: e_1_3_2_34_2
  doi: 10.1038/nrm909
– ident: e_1_3_2_50_2
  doi: 10.1128/JVI.79.9.5414-5420.2005
– ident: e_1_3_2_44_2
  doi: 10.1016/j.jmb.2013.11.023
– ident: e_1_3_2_62_2
  doi: 10.1038/nrmicro.2016.125
– ident: e_1_3_2_32_2
  doi: 10.1038/nrmicro2950
– ident: e_1_3_2_98_2
  doi: 10.1016/j.chom.2007.09.003
– ident: e_1_3_2_2_2
  doi: 10.1016/j.chom.2016.03.010
– ident: e_1_3_2_48_2
  doi: 10.1128/JVI.74.11.4957-4966.2000
– ident: e_1_3_2_103_2
  doi: 10.1016/j.it.2015.02.002
– ident: e_1_3_2_89_2
  doi: 10.1038/sj.onc.1203482
– ident: e_1_3_2_68_2
  doi: 10.1016/j.chom.2014.07.015
– ident: e_1_3_2_81_2
  doi: 10.1016/j.vaccine.2009.03.007
– ident: e_1_3_2_69_2
  doi: 10.1016/j.immuni.2012.11.013
– ident: e_1_3_2_29_2
  doi: 10.1128/JVI.80.6.2913-2923.2006
– ident: e_1_3_2_37_2
  doi: 10.1128/JVI.00176-10
– ident: e_1_3_2_14_2
  doi: 10.1016/j.jmb.2016.07.017
– ident: e_1_3_2_9_2
  doi: 10.1146/annurev-immunol-032713-120231
– ident: e_1_3_2_56_2
  doi: 10.1128/JVI.73.11.9247-9255.1999
– ident: e_1_3_2_78_2
  doi: 10.1128/JVI.02097-12
– ident: e_1_3_2_72_2
  doi: 10.1016/S0065-3527(03)61008-0
– ident: e_1_3_2_61_2
  doi: 10.1128/mBio.01316-15
– ident: e_1_3_2_47_2
  doi: 10.1128/JVI.79.20.12828-12839.2005
– ident: e_1_3_2_59_2
  doi: 10.1016/j.chom.2010.10.007
– ident: e_1_3_2_88_2
  doi: 10.1093/emboj/18.4.959
– ident: e_1_3_2_106_2
  doi: 10.1128/JVI.00271-09
– ident: e_1_3_2_110_2
  doi: 10.1371/journal.ppat.1004682
– ident: e_1_3_2_27_2
  doi: 10.1016/j.virol.2015.01.019
– ident: e_1_3_2_21_2
  doi: 10.4161/jkst.27715
– ident: e_1_3_2_91_2
  doi: 10.1371/journal.ppat.1005143
– ident: e_1_3_2_12_2
  doi: 10.1038/nri3133
– ident: e_1_3_2_70_2
  doi: 10.1007/978-3-642-37765-5_2
– ident: e_1_3_2_97_2
  doi: 10.1128/JVI.00791-07
– ident: e_1_3_2_8_2
  doi: 10.1038/nri3210
– ident: e_1_3_2_4_2
  doi: 10.1371/journal.pntd.0004682
– ident: e_1_3_2_79_2
  doi: 10.1007/s00726-008-0055-4
– ident: e_1_3_2_7_2
  doi: 10.1016/j.cell.2016.08.004
– ident: e_1_3_2_73_2
  doi: 10.1128/JVI.02830-06
– ident: e_1_3_2_71_2
  doi: 10.1128/JVI.02505-14
– ident: e_1_3_2_87_2
  doi: 10.1002/pmic.201300001
– ident: e_1_3_2_77_2
  doi: 10.1128/JVI.02050-10
– ident: e_1_3_2_33_2
  doi: 10.1038/nri3581
– ident: e_1_3_2_20_2
  doi: 10.3389/fmicb.2013.00176
– ident: e_1_3_2_40_2
  doi: 10.1016/j.chom.2008.10.007
– ident: e_1_3_2_65_2
  doi: 10.15252/embr.201642627
– ident: e_1_3_2_107_2
  doi: 10.1016/j.ymeth.2011.08.003
– ident: e_1_3_2_102_2
  doi: 10.1016/j.chom.2013.07.005
– ident: e_1_3_2_13_2
  doi: 10.1038/nri3865
– ident: e_1_3_2_85_2
  doi: 10.1111/j.1462-5822.2007.01076.x
– ident: e_1_3_2_28_2
  doi: 10.1016/j.chom.2015.06.007
– ident: e_1_3_2_17_2
  doi: 10.1126/science.aaf8325
– ident: e_1_3_2_41_2
  doi: 10.1128/JVI.00207-12
– ident: e_1_3_2_16_2
  doi: 10.1016/j.mib.2010.05.009
– ident: e_1_3_2_63_2
  doi: 10.1128/JVI.00252-16
– ident: e_1_3_2_105_2
  doi: 10.1371/journal.ppat.1005451
– ident: e_1_3_2_90_2
  doi: 10.1074/jbc.M309749200
– ident: e_1_3_2_80_2
  doi: 10.1128/JVI.00768-06
– ident: e_1_3_2_75_2
  doi: 10.1371/journal.ppat.1000721
– ident: e_1_3_2_49_2
  doi: 10.4049/jimmunol.174.12.8163
– ident: e_1_3_2_82_2
  doi: 10.1128/JVI.78.17.9285-9294.2004
– ident: e_1_3_2_52_2
  doi: 10.1038/nrmicro2595
– ident: e_1_3_2_76_2
  doi: 10.1089/jir.2012.0117
– ident: e_1_3_2_10_2
  doi: 10.1038/nature09907
– start-page: 1101
  volume-title: Fields virology
  year: 2007
  ident: e_1_3_2_23_2
– ident: e_1_3_2_45_2
  doi: 10.3390/v4030397
– ident: e_1_3_2_101_2
  doi: 10.1371/journal.pone.0090704
– ident: e_1_3_2_39_2
  doi: 10.1038/nrmicro2675
– ident: e_1_3_2_74_2
  doi: 10.1128/JVI.02283-06
– ident: e_1_3_2_109_2
  doi: 10.1128/JVI.01239-15
– ident: e_1_3_2_15_2
  doi: 10.1016/j.it.2015.01.004
– ident: e_1_3_2_18_2
  doi: 10.1016/j.cytogfr.2014.08.004
– ident: e_1_3_2_67_2
  doi: 10.1099/vir.0.014506-0
– ident: e_1_3_2_86_2
  doi: 10.1128/JVI.02714-05
– ident: e_1_3_2_111_2
  doi: 10.1371/journal.ppat.1002934
– ident: e_1_3_2_55_2
  doi: 10.1086/605847
– ident: e_1_3_2_94_2
  doi: 10.1016/j.chom.2016.06.001
– ident: e_1_3_2_26_2
  doi: 10.1038/nature09489
– ident: e_1_3_2_38_2
  doi: 10.4161/viru.2.3.16162
– ident: e_1_3_2_53_2
  doi: 10.1038/nature12060
– ident: e_1_3_2_84_2
  doi: 10.1128/JVI.01161-09
– ident: e_1_3_2_99_2
  doi: 10.1128/JVI.80.9.4623-4632.2006
– ident: e_1_3_2_25_2
  doi: 10.1073/pnas.1514978112
– ident: e_1_3_2_31_2
  doi: 10.1128/JVI.01305-07
– volume: 321
  start-page: 85
  year: 2008
  ident: e_1_3_2_35_2
  article-title: Innate resistance to flavivirus infections and the functions of 2′-5′ oligoadenylate synthetases
  publication-title: Curr Top Microbiol Immunol
– ident: e_1_3_2_3_2
  doi: 10.4269/ajtmh.16-0111
– ident: e_1_3_2_30_2
  doi: 10.1128/JVI.01488-13
– ident: e_1_3_2_51_2
  doi: 10.1128/JVI.79.3.1343-1350.2005
– ident: e_1_3_2_11_2
  doi: 10.1038/nri3806
– ident: e_1_3_2_43_2
  doi: 10.1089/jir.2009.0069
– ident: e_1_3_2_92_2
  doi: 10.1128/JVI.79.3.1934-1942.2005
– ident: e_1_3_2_96_2
  doi: 10.1073/pnas.2335168100
– start-page: 1153
  volume-title: Fields virology
  year: 2007
  ident: e_1_3_2_22_2
– ident: e_1_3_2_46_2
  doi: 10.1016/j.vaccine.2012.11.015
– ident: e_1_3_2_66_2
  doi: 10.1016/j.stem.2016.08.005
– ident: e_1_3_2_6_2
  doi: 10.1016/j.cell.2016.05.008
– ident: e_1_3_2_108_2
  doi: 10.1371/journal.ppat.1003549
SSID ssj0014464
Score 2.5730448
SecondaryResourceType review_article
Snippet The vector-borne flaviviruses cause severe disease in humans on every inhabited continent on earth. Their transmission by arthropods, particularly mosquitoes,...
SourceID pubmedcentral
proquest
pubmed
crossref
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
SubjectTerms Animals
Arthropod Vectors - virology
Arthropoda
Flaviviridae
Flavivirus
Flavivirus - classification
Flavivirus - physiology
Flavivirus Infections - metabolism
Flavivirus Infections - transmission
Flavivirus Infections - virology
Host-Pathogen Interactions
Humans
Interferon Type I - antagonists & inhibitors
Interferon Type I - metabolism
Janus Kinases - metabolism
Minireview
Protein Binding
Signal Transduction
STAT Transcription Factors - metabolism
Structure-Activity Relationship
Viral Nonstructural Proteins - chemistry
Viral Nonstructural Proteins - metabolism
Viral Proteins - metabolism
West Nile virus
Zika virus
Title The Many Faces of the Flavivirus NS5 Protein in Antagonism of Type I Interferon Signaling
URI https://www.ncbi.nlm.nih.gov/pubmed/27881649
https://www.proquest.com/docview/1843969302
https://www.proquest.com/docview/1868335298
https://pubmed.ncbi.nlm.nih.gov/PMC5244349
Volume 91
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnZ3db9MwEMAtGELiBfFN-ZKR4KlKSezEiR8BUa1D5WUbKk-RP0fRlE5dOwn-eu6cNEm3ggZSlUbppWnza893Pt8dIW9Y4a21RkecKxWlLFaRtnEMe0w6bzOeG4zoTr-I_eP0YJbNuj56IbtkpUfm1868kv-hCseAK2bJ_gPZ9k3hAOwDX9gCYdhem_EUA_bjsLCqCfePT9XF_GK-XIMKO8wwFQA7WoaJjQpjUBX2xQBZdEGHk3pO0LslKo75CdrlzWB21WTFnLj-LPwHV2eMHC6qH2o4HfWnEGBYitvlGN2SftB8s3pQqDUhFhpFc6qvKmXS-0nw3RqYYVbBwdfJCIzHPI6SHYWuLw1A7bLA4JCwooSzy3B2mYib5BYDDyB4y5PPbYAIvNh0UwgeP_kmp4EV7_rX3rY2rrgQl1fC9kyLo3vkbnOD6fsa8H1yw1UPyO26S-jPh-QbYKaImQbMdOEpYKYdZgqYaYOZwqPDjLKImU5oh5m2mB-R4_Gno4_7UdMRIzJpwVcRL3TONdi8xnKfeK48M0LBs2TapLZQPk9Sk8Qu4wIL7VkmpBZGxTJ34Hoq_pjsVYvKPSXUSyNim2fWW5-yPNaJsMxo0NDOq5iZARlu7lxpmnLx2LXktNxFaUDettJndZmUP8i93kAoQY9hcEpVbrE-L7HvkMS-nOxvMiLkCMpiQJ7U4NqrMeyLIFI5IPkW0lYA66hvv1LNv4d66hmYuDyVz675HZ6TO92f6AXZWy3X7iVYpiv9KvxGfwNaWYz9
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=The+Many+Faces+of+the+Flavivirus+NS5+Protein+in+Antagonism+of+Type+I+Interferon+Signaling&rft.jtitle=Journal+of+virology&rft.au=Best%2C+Sonja+M.&rft.date=2017-02-01&rft.issn=0022-538X&rft.eissn=1098-5514&rft.volume=91&rft.issue=3&rft_id=info:doi/10.1128%2FJVI.01970-16&rft.externalDBID=n%2Fa&rft.externalDocID=10_1128_JVI_01970_16
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-538X&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-538X&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-538X&client=summon